The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system
<p>Abstract</p> <p>Background</p> <p>Previous studies have demonstrated that intrathecal administration of the substance P amino-terminal metabolite substance P<sub>1-7 </sub>(SP<sub>1-7</sub>) and its C-terminal amidated congener induced antihyp...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2011-10-01
|
Series: | Molecular Pain |
Subjects: | |
Online Access: | http://www.molecularpain.com/content/7/1/85 |
id |
doaj-ccc08fe64b194aeea0183cc036ed81f1 |
---|---|
record_format |
Article |
spelling |
doaj-ccc08fe64b194aeea0183cc036ed81f12020-11-25T04:03:12ZengSAGE PublishingMolecular Pain1744-80692011-10-01718510.1186/1744-8069-7-85The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor systemOhsawa MasahiroCarlsson AnnaAsato MegumiKoizumi TakayukiNakanishi YukiFransson RebeccaSandström AnjaHallberg MathiasNyberg FredKamei Junzo<p>Abstract</p> <p>Background</p> <p>Previous studies have demonstrated that intrathecal administration of the substance P amino-terminal metabolite substance P<sub>1-7 </sub>(SP<sub>1-7</sub>) and its C-terminal amidated congener induced antihyperalgesic effects in diabetic mice. In this study, we studied a small synthetic dipeptide related to SP<sub>1-7 </sub>and endomorphin-2, i.e. Phe-Phe amide, using the tail-flick test and von Frey filament test in diabetic and non-diabetic mice.</p> <p>Results</p> <p>Intrathecal treatment with the dipeptide increased the tail-flick latency in both diabetic and non-diabetic mice. This effect of Phe-Phe amide was significantly greater in diabetic mice than non-diabetic mice. The Phe-Phe amide-induced antinociceptive effect in both diabetic and non-diabetic mice was reversed by the σ<sub>1 </sub>receptor agonist (+)-pentazocine. Moreover, Phe-Phe amide attenuated mechanical allodynia in diabetic mice, which was reversible by (+)-pentazocine. The expression of spinal σ1 receptor mRNA and protein did not differ between diabetic mice and non-diabetic mice. On the other hand, the expression of phosphorylated extracellular signal-regulated protein kinase 1 (ERK1) and ERK2 proteins was enhanced in diabetic mice. (+)-Pentazocine caused phosphorylation of ERK1 and ERK2 proteins in non-diabetic mice, but not in diabetic mice.</p> <p>Conclusions</p> <p>These results suggest that the spinal σ<sub>1 </sub>receptor system might contribute to diabetic mechanical allodynia and thermal hyperalgesia, which could be potently attenuated by Phe-Phe amide.</p> http://www.molecularpain.com/content/7/1/85AllodyniaAntinociceptionDiabetesHyperalgesiaOpioid receptorsPhe-Phe amideσ<sub>1 </sub>receptorSubstance P<sub>1-7</sub> |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ohsawa Masahiro Carlsson Anna Asato Megumi Koizumi Takayuki Nakanishi Yuki Fransson Rebecca Sandström Anja Hallberg Mathias Nyberg Fred Kamei Junzo |
spellingShingle |
Ohsawa Masahiro Carlsson Anna Asato Megumi Koizumi Takayuki Nakanishi Yuki Fransson Rebecca Sandström Anja Hallberg Mathias Nyberg Fred Kamei Junzo The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system Molecular Pain Allodynia Antinociception Diabetes Hyperalgesia Opioid receptors Phe-Phe amide σ<sub>1 </sub>receptor Substance P<sub>1-7</sub> |
author_facet |
Ohsawa Masahiro Carlsson Anna Asato Megumi Koizumi Takayuki Nakanishi Yuki Fransson Rebecca Sandström Anja Hallberg Mathias Nyberg Fred Kamei Junzo |
author_sort |
Ohsawa Masahiro |
title |
The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system |
title_short |
The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system |
title_full |
The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system |
title_fullStr |
The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system |
title_full_unstemmed |
The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system |
title_sort |
dipeptide phe-phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system |
publisher |
SAGE Publishing |
series |
Molecular Pain |
issn |
1744-8069 |
publishDate |
2011-10-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Previous studies have demonstrated that intrathecal administration of the substance P amino-terminal metabolite substance P<sub>1-7 </sub>(SP<sub>1-7</sub>) and its C-terminal amidated congener induced antihyperalgesic effects in diabetic mice. In this study, we studied a small synthetic dipeptide related to SP<sub>1-7 </sub>and endomorphin-2, i.e. Phe-Phe amide, using the tail-flick test and von Frey filament test in diabetic and non-diabetic mice.</p> <p>Results</p> <p>Intrathecal treatment with the dipeptide increased the tail-flick latency in both diabetic and non-diabetic mice. This effect of Phe-Phe amide was significantly greater in diabetic mice than non-diabetic mice. The Phe-Phe amide-induced antinociceptive effect in both diabetic and non-diabetic mice was reversed by the σ<sub>1 </sub>receptor agonist (+)-pentazocine. Moreover, Phe-Phe amide attenuated mechanical allodynia in diabetic mice, which was reversible by (+)-pentazocine. The expression of spinal σ1 receptor mRNA and protein did not differ between diabetic mice and non-diabetic mice. On the other hand, the expression of phosphorylated extracellular signal-regulated protein kinase 1 (ERK1) and ERK2 proteins was enhanced in diabetic mice. (+)-Pentazocine caused phosphorylation of ERK1 and ERK2 proteins in non-diabetic mice, but not in diabetic mice.</p> <p>Conclusions</p> <p>These results suggest that the spinal σ<sub>1 </sub>receptor system might contribute to diabetic mechanical allodynia and thermal hyperalgesia, which could be potently attenuated by Phe-Phe amide.</p> |
topic |
Allodynia Antinociception Diabetes Hyperalgesia Opioid receptors Phe-Phe amide σ<sub>1 </sub>receptor Substance P<sub>1-7</sub> |
url |
http://www.molecularpain.com/content/7/1/85 |
work_keys_str_mv |
AT ohsawamasahiro thedipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem AT carlssonanna thedipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem AT asatomegumi thedipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem AT koizumitakayuki thedipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem AT nakanishiyuki thedipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem AT franssonrebecca thedipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem AT sandstromanja thedipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem AT hallbergmathias thedipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem AT nybergfred thedipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem AT kameijunzo thedipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem AT ohsawamasahiro dipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem AT carlssonanna dipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem AT asatomegumi dipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem AT koizumitakayuki dipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem AT nakanishiyuki dipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem AT franssonrebecca dipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem AT sandstromanja dipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem AT hallbergmathias dipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem AT nybergfred dipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem AT kameijunzo dipeptidephepheamideattenuatessignsofhyperalgesiaallodyniaandnociceptionindiabeticmiceusingamechanisminvolvingthesigmareceptorsystem |
_version_ |
1724441256302477312 |